Skip to main content
. 2021 May 12;92(2):e2021028. doi: 10.23750/abm.v92i2.9678

Table 3.

Comparison of miRNA in breast cancer (ca) and healthy controls (Delta181CT)

miRNA Mean ± Standard Deviation Median P value
mir125
Breast ca (n=20) 0.94373002050±2.393207166077 0.98937177650 < 0.001*
Controls (n=19) -2.43345320853±2.627056151939 -2.78703117400
mir21
Breast ca (n=20) -1.66752185820±3.346716227004 -1.29511690100 0.032*
Controls (n=19) -3.75930996947±2.391387065653 -3.90891838100
mir155
Breast ca (n=18) 3.87487157183±3.324017758150 3.21931839000 < 0.001
Control s (n=17) 0.04327908682±1.606969131983 0.65145111100
mir335
Breast ca (n=16) -1.73451858756±2.986015580539 -0.60250520750 0.052*
Controls (n=19) -3.60843758826±2.504742945574 -3.58927345300
mir27b5p
Breast ca (n=14) -7.02835486508±3.739053080008 -6.53322410600 0.381*
Controls (n=19) -8.27098565447±3.971230704023 -8.97427368200
mir200c
Breast cancer (n=12) -4.91058476775±2.327751440005 -5.15111017250 0.723*
Controls (n=12) -4.43942181267±3.889838833217 -4.72640895850
mir373
Breast ca (n=2) 3.74489450463±4.777039907303 5.07454586050 1.000
Controls (n=8) 4.91632747650±0.228309140564 4.91632747650

Legend:*Independent samples t test;†:Mann-Whitney U test